Skip to content

Comparison of the Effectiveness of an Empowerment Intervention on Health Anxiety and Sexual Distress in HPV Positive Women

Comparison of the Effectiveness of an Empowerment Intervention on Health Anxiety and Sexual Distress in HPV Positive Women: A Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150128020854N14
Enrollment
112
Registered
2024-07-03
Start date
2024-06-21
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Human papillomavirus. Condition 2: Health anxiety. Condition 3: Sexual distress. Other predominantly sexually transmitted diseases, not elsewhere classified Hypochondriacal disorders Reaction to severe stress, and adjustment disorders

Interventions

Intervention 1: Intervention group: For women in the intervention group, two 90-minute group training and counseling sessions will be held one week apart. The number of participants in each group will

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Have Iranian nationality. At least they should be able to read and write. Be at the reproductive age. Lack of speech, hearing or mental disorders that prevent communication with the researcher. Have a positive high-risk HPV test (with or without low-risk strains) with normal cytology in the last 2 weeks. Do not have a history of HPV infection. (According to the statement of the women) Do not have a history of receiving the HPV vaccine. Have sexual activity. Do not be in pregnancy or breastfeeding period. Suffering from other diseases is not mentioned in their medical records. Do not have a history of suffering from neurological and mental diseases such as depression and taking related drugs. (According to the statement of the women) Lack of specific event or incident that represents a crisis in their life, such as death or incurable illness of family members and loss of job since 6 months ago and marital infidelity, and not being on the verge of divorce.

Exclusion criteria

Exclusion criteria: Have a positive low-risk HPV test without high-risk strains. Have abnormal cytology. Have a history of HPV infection or HPV vaccine. Have a disease other than HPV. do not want to participate in the study.

Design outcomes

Primary

MeasureTime frame
Health Anxiety. Timepoint: Before the intervention, 4 week after intervention. Method of measurement: Short Health Anxiety Inventory (SHAI).;Sexual Distress. Timepoint: Before the intervention, 4 week after intervention. Method of measurement: The Female Sexual Distress Scale-Revised (FSDS-R).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanieh Sabzalian

Shahid Beheshti University of Medical Sciences

h.sabzalian@sbmu.ac.ir+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026